Baxter International (BAX) Scheduled to Post Earnings on Friday

Baxter International (NYSE:BAX) is set to issue its quarterly earnings data before the market opens on Friday, November 8th. Analysts expect the company to announce earnings of $0.78 per share for the quarter. Parties interested in participating in the company’s conference call can do so using this link.

Baxter International (NYSE:BAX) last announced its quarterly earnings data on Tuesday, August 6th. The medical instruments supplier reported $0.68 EPS for the quarter, topping analysts’ consensus estimates of $0.66 by $0.02. Baxter International had a return on equity of 18.06% and a net margin of 16.51%. The business had revenue of $3.81 billion during the quarter, compared to analysts’ expectations of $3.75 billion. During the same period in the previous year, the firm earned $0.55 earnings per share. The firm’s quarterly revenue was up 2.8% compared to the same quarter last year. On average, analysts expect Baxter International to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Baxter International Stock Down 0.4 %

Shares of Baxter International stock opened at $35.70 on Friday. The company has a quick ratio of 0.91, a current ratio of 1.40 and a debt-to-equity ratio of 1.35. Baxter International has a 12 month low of $32.06 and a 12 month high of $44.01. The business has a fifty day simple moving average of $37.64 and a 200 day simple moving average of $36.29. The stock has a market cap of $18.21 billion, a PE ratio of 7.35, a price-to-earnings-growth ratio of 1.28 and a beta of 0.59.

Wall Street Analyst Weigh In

BAX has been the topic of several recent analyst reports. Morgan Stanley lowered Baxter International from an “equal weight” rating to an “underweight” rating and reduced their target price for the stock from $39.00 to $30.00 in a report on Monday, July 15th. JPMorgan Chase & Co. reduced their target price on Baxter International from $44.00 to $42.00 and set a “neutral” rating on the stock in a report on Wednesday, August 7th. StockNews.com upgraded Baxter International from a “hold” rating to a “buy” rating in a report on Tuesday, October 22nd. The Goldman Sachs Group lifted their target price on Baxter International from $36.00 to $40.00 and gave the stock a “neutral” rating in a report on Thursday, August 8th. Finally, Wells Fargo & Company reduced their target price on Baxter International from $44.00 to $40.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company. According to MarketBeat, Baxter International presently has an average rating of “Hold” and an average price target of $41.20.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.